Volume 33, Issue 2 pp. 108-111

Daily versus intermittent application of high-concentration tacalcitol ointment in combination with low-dose cyclosporin for psoriasis vulgaris

Masatoshi ABE

Masatoshi ABE

Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan

Search for more papers by this author
Tomoko SYUTO

Tomoko SYUTO

Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan

Search for more papers by this author
Michiko HASEGAWA

Michiko HASEGAWA

Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan

Search for more papers by this author
Yoko SOGABE

Yoko SOGABE

Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan

Search for more papers by this author
Yoko YOKOYAMA

Yoko YOKOYAMA

Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan

Search for more papers by this author
Osamu ISHIKAWA

Osamu ISHIKAWA

Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan

Search for more papers by this author
First published: 07 March 2006
Citations: 8
Masatoshi Abe, M.D., Ph.D., Department of Dermatology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi 371-8511, Japan. Email: [email protected]

ABSTRACT

In this study, we aimed to compare the clinical effectiveness of highly-concentrated tacalcitol ointment daily versus intermittent application in patients with psoriasis vulgaris who simultaneously took a low dose of cyclosporin. All the patients in both groups showed significant improvements, and the patients in the intermittent application group obtained more patient satisfaction in cost performance. The treatment cost of low-dose cyclosporin and intermittent application of highly-concentrated tacalcitol ointment was less than half of that of high-dose cyclosporin and daily application of highly-concentrated tacalcitol ointment. This preliminary study suggests that the combination therapy with low-dose cyclosporin administration and intermittent application of highly-concentrated tacalcitol is effective, safe and provides acceptable costs for the treatment.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.